搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
来自MSN
12 小时
Robotic-assisted surgery for uterus prolapse shows promise: Study
"Almost every second woman suffers from a pelvic floor disorder in the course of her life," explains Prof. Dr. Dominique ...
FierceBiotech
17 小时
It’s all about the Journey: Entero inks reverse merger with ADC rival biotech
Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...
Chicago Parent
14 小时
Why Your Child May Need to See a Gynecologist Earlier Than You Think
How early is too early to introduce your child to a gynecologist? Experts at UChicago Medicine share what you need to know.
10 小时
on MSN
All in the blood: New way to detect drug resistance in ovarian cancer patients
Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...
7 小时
Zentalis Pharmaceuticals Announces New Leadership and Strategy Shift
The latest announcement is out from Zentalis Pharmaceuticals ( (ZNTL) ). Zentalis Pharmaceuticals is undergoing significant leadership changes ...
来自MSN
14 小时
Health Horoscope Today November 14, 2024: Try to avoid oily food
Be very careful while participating in adventure activities. Athletes and sportspersons might get injured while playing. Some ...
15 小时
Entero Therapeutics announces proposed reverse merger with Journey Therapeutics
Entero Therapeutics (ENTO) has entered into a binding term sheet for a reverse merger transaction with Journey Therapeutics. Upon completion of ...
Greenwich Time
17 小时
Harrods sex trafficking lawsuit seeks ‘critical evidence’ from Greenwich brother of ...
Greenwich resident Ali Fayed has been asked to provide information on alleged Harrods trafficking operation and the actions ...
Yahoo Finance
19 小时
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned ...
“The azenosertib clinical results generated to date are compelling, and we believe this investigational medicine has the potential to become an important new treatment option for a significant segment ...
manilatimes
19 小时
Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈